|

GENE THERAPY
THE STATE OF THE ART
Dr. Abdel Aziz El Bayoumi
Professor of Genetics
Dr. Khalid Al Ali
Lecturer of Genetics
Department of Biological Sciences
University of Qatar, Doha
|
|
9. GENERATION OF MOUSE MODELS FOR GENE THERAPY
Normally, gene therapy like any other administration of a new drug has to be tested in animal
model, before clinical application on human. Mice
are good candidates for administering and studying the effect of new drugs. The mice have to
be prepared in way to generate genetically manipulated mice, for example that carry or lack
a specific gene. These mice provide tools to analyze the function of new genes in a whole
organism environment and provide a model of a human disease.
The introduction of any gene to be incorporated within the genome, form what is known as
transgenic mice. Therefore, it is possible to introduce specific gene together with promoter
region, which will be expressed in specific tissue and forming the final protein product.
Normally the gene of interest is cloned and constructed then injected into the pronuclei of
fertilized mouse eggs, leading to the integration of this DNA into the mouse genome. The
injected eggs are transplanted into female. Expression
of the gene and any resultant phenotypic changes can then be studied. (Figure 15)
Transegenic mice are normally used in gene therapy to show the expression targeting types
and longevity of the gene expression (Tsukui, 1996).
|